FY 2022 ICD-10-CM update: Guidelines fill in the details for reporting new post COVID-19 code

Why This Topic Matters

These guideline updates affect how certain common diagnosis and status scenarios are reported under ICD-10-CM starting in FY 2022. Understanding the scope of the changes helps coding teams align documentation review and code assignment practices with the updated official guidance.

Article Sections

1. Post-COVID-19 condition guidance

   Overview of the new ICD-10-CM guidance addressing reporting for patients with prior COVID-19 infection and related follow-up circumstances.

2. Laterality documentation and unspecified codes

   Discussion of updated guidance on using documentation from other clinicians when side is not directly documented and on when unspecified reporting may be appropriate.

3. HIV patients on antiretroviral medications

   Summary of the guideline update addressing patients with a documented HIV history who are receiving long-term antiretroviral therapy.

4. Diabetes patients on oral medications and insulin

   Overview of the update for diabetic patients treated with both oral medications and insulin under the FY 2022 guideline changes.

5. Effective date and code set reference

   Notes the effective date of the guideline changes and references the FY 2022 ICD-10-CM code set.